|
| Lung Primary | Breast Primary | ||
| Tumor staging | Stage I | 18 (51%) | Stage 0 | 2 (6%) |
| Stage II | 6 (17%) | Stage I | 15 (43%) | |
| Stage III | 6 (17%) | Stage II | 13 (37%) | |
| Stage IV | 5 (14%) | Stage III | 4 (11%) | |
|
|
| Stage IV | 1 (3%) | |
| Tumor subtypesb | Adenocarcinoma | 19 (54%) | IDC | 24 (69%) |
| NSCLC NOS | 6 (17%) | ILC | 7 (20%) | |
| Squamous cell carcinoma | 3 (9%) | DCIS | 2 (6%) | |
| Large cell lung cancer | 4 (11%) | Carcinoma NOS | 2 (6%) | |
| Small cell lung cancer | 2 (6%) |
|
| |
| Carcinoma NOS | 1 (3%) |
|
| |